BEOVU in the Treatment of Dystrophy-related Macular Neovascular Degeneration

• Status: Recruiting
• Trial end date: 2022-12-30
• Target enrollment: 0
• Participant gender: All

Summary

Dystrophy-Related macular neovascularization degeneration occur is a vision threatening condition.The investigators evaluate the efficacy of BEOVU intravitreal treatment.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Benha University

Criteria

Inclusion Criteria:

• Dystrophy-Related macular neovascularization degeneration

Exclusion Criteria:

• age related macular degeneration , other causes of macular neovascularization degeneration